Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors

Front Pharmacol. 2020 Sep 25:11:598858. doi: 10.3389/fphar.2020.598858. eCollection 2020.

Authors

John D Imig¹, Christophe Morisseau²

Affiliations

¹ Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, United States.
² Department of Entomology and Nematology, University of California at Davis, Davis, CA, United States.

No abstract available

Keywords: eicosanoids, oxylipins; heart disease; inflammation; kidney disease; neurological diseases; pain.

Publication types

Editorial

Grants and funding

R35 ES030443/ES/NIEHS NIH HHS/United States